Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Peptomyc

Peptomyc
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
6 INVESTORS
Description

Developer of peptide therapeutics designed to treat cancer. The company is developing peptide therapeutics targeting the Myc oncogene, a central function in cancer cell survival, that allows cancer cells to divide and survive treatment, providing cancer patients with an improved survival chance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Barcelona
  • Spain
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Peptomyc’s full profile, request a free trial.

Peptomyc Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 12-Jun-2018 00.000 Completed Startup
3. Early Stage VC (Series A) 06-Sep-2017 00.000 00.000 Completed Startup
2. Seed Round 28-Apr-2016 $1.13M $1.13M Completed Startup
1. Grant 25-Feb-2016 $2.22M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Peptomyc Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
EIT Health Accelerator/Incubator Minority 000 0000 000000 0
Alta Life Sciences Venture Capital Minority 000 0000 000000 0
Healthequity (Spain) Venture Capital Minority 000 0000 000000 0
ACCIÓ Government 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Peptomyc Executive Team (4)

Name Title Board
Seat
Contact
Info
Laura Soucek Ph.D Co-Founder, Chief Executive Officer & Board Member
Jordi Salamó Chief Financial Officer
Marie-Eve Beaulieu Ph.D Chief Scientific Officer & Co-Founder
Xavier Vengohechea Manager, Business Development

Peptomyc Board Members (1)

Name Representing Role Since Contact
Info
Laura Soucek Ph.D Peptomyc Co-Founder, Chief Executive Officer & Board Member 000 0000